Fourth Quarter Update The Company also provided an update on several topics related to its fiscal 2025 fourth quarter, which...
Appointment
SOUTH SAN FRANCISCO, Calif., Feb. 10, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a precision medicine oncology company committed...
